Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab
Clinical trial NCT03200977 · COMPLETED
Trial details
- NCT number
- NCT03200977
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-01
- Primary completion
- 2022-06-03
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.